Press Releases

Date Title View
Toggle SummaryFebruary 27, 2018 GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results
CARLSBAD, Calif. , Feb. 27, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and full year ended December 31, 2017 .
View HTML
Toggle SummaryFebruary 21, 2018 GenMark Diagnostics to Present at Upcoming Investor Conferences
CARLSBAD, Calif. , Feb. 21, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that the Company plans to participate in two upcoming investor conferences. March 1, 2018 , GenMark’s management is scheduled to participate in the BTIG Snowbird Healthcare Conference in
View HTML
Toggle SummaryFebruary 13, 2018 GenMark Diagnostics Schedules Fourth Quarter and Full Year 2017 Financial Results Conference Call for February 27, 2018
CARLSBAD, Calif. , Feb. 13, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its fourth quarter earnings results after market close on Tuesday, February 27, 2018. Management will hold a conference call to review the Company's financial
View HTML
Toggle SummaryJanuary 9, 2018 GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2017
CARLSBAD, Calif. , Jan. 09, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2017 .
View HTML
Toggle SummaryDecember 21, 2017 GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference
CARLSBAD, Calif. , Dec. 21, 2017 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany , will present at the J.P.
View HTML
Toggle SummaryNovember 7, 2017 GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
CARLSBAD, Calif. --(BUSINESS WIRE)--Nov. 7, 2017-- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany , will present at the Canaccord Genuity Medical
View HTML
Toggle SummaryNovember 2, 2017 GenMark Diagnostics Reports Third Quarter 2017 Results
CARLSBAD, Calif. --(BUSINESS WIRE)--Nov. 2, 2017-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the third quarter ended September 30, 2017 .
View HTML
Toggle SummaryOctober 19, 2017 GenMark Diagnostics Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
CARLSBAD, Calif. --(BUSINESS WIRE)--Oct. 19, 2017-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Thursday, November 2, 2017 . Management will hold a conference call to review the Company's financial
View HTML
Toggle SummaryOctober 19, 2017 GenMark Diagnostics Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
CARLSBAD, Calif. --(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Thursday, November 2, 2017 . Management will hold a conference call to review the Company's financial performance starting
View HTML
Toggle SummaryAugust 1, 2017 GenMark Reports Second Quarter 2017 Results
Second Quarter Revenue of $12.4 million Ended the Quarter with Over 80 ePlex ® Instruments Installed at Customer Sites CARLSBAD, Calif. --(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced
View HTML